• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.08% Nasdaq Down 0.35%

    More On SAN.PA

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Sanofi (SAN.PA)

    -Paris
    68.94 Down 0.97(1.39%) Feb 9
    Prev Close:68.94
    Open:71.31
    Bid:68.80 x 14500
    Ask:69.20 x 114500
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:67.83 - 71.50
    52wk Range:67.83 - 89.95
    Volume:5,709,276
    Avg Vol (3m):N/A
    Market Cap:90.45B
    P/E (ttm):17.24
    EPS (ttm):4.00
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in EUR.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2.42
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Sanofi researches, develops, and markets various therapeutic solutions. Its products comprise diabetes solutions, including Lantus, Apidra, and Insuman that are human insulin analogs; Amaryl, an oral sulfonylurea; Lyxumia, a glucagon-like peptide-... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback